FSFatma Sargın

Fatma Sargın

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fatma Sargın has a total of 73 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical Spectrum, Outcomes, and Factors Associated With Encephalopathy in Children With Influenza‐Associated Neurological Complications: A Retrospective Cohort Study

    by Süleyman Şahin, Gonca Başak Soran, Büşra Kaygusuz Aydemir, Fatma Sargin, Mustafa Gençeli, Abdullah Akkuş, Halil Çelik, Özge Metin Akcan, Ahmet Sami Güven

    Objective: This study aims to characterize the clinical spectrum, outcomes, and factors associated with influenza‐associated encephalopathy in hospitalized children with influenza‐associated neurological complications. Methods: This retrospective cohort study included children younger than 18 years who were hospitalized with laboratory‐confirmed influenza at a tertiary university hospital between 2018 and 2023. We reviewed demographic, clinical, laboratory, neuroimaging, electroencephalographic, cerebrospinal fluid, treatment, and outcome data. Patients with and without encephalopathy were compared, and multivariable logistic regression analysis was performed to identify factors independently associated with influenza‐associated encephalopathy. Results: Among 3040 hospitalized children with laboratory‐confirmed influenza, 115 (3.8%) developed influenza‐associated neurological complications. The median age was 32 months (interquartile range [IQR], 19–58 months), and 67 (58.3%) were male. Influenza A accounted for 80.0% of infections. Seizures were the presenting neurological manifestation in all patients, with generalized tonic–clonic seizures occurring in 101 (87.8%). Encephalopathy and encephalitis were identified in 15 (13.0%) and 11 (9.6%) patients, respectively. Two patients (1.7%) were diagnosed with acute necrotizing encephalopathy (ANE). Most children recovered without permanent neurological deficits; however, one patient developed persistent neurological sequelae and two died during hospitalization. In multivariable analysis, focal seizures (adjusted odds ratio [aOR], 16.98; 95% confidence interval [CI], 3.42–84.27; p = 0.001) and higher lymphocyte counts (aOR, 1.53 per 1000 cells/mm 3 increase; 95% CI, 1.11–2.12; p = 0.009) were independently associated with influenza‐associated encephalopathy. Conclusion: Seizures predominantly characterized influenza‐associated neurological complications in hospitalized children and generally had favorable short‐term outcomes. However, influenza‐associated encephalopathy was associated with substantially greater clinical severity, including prolonged hospitalization, more frequent pediatric intensive care unit admission, and poorer in‐hospital outcomes. Recognition of focal seizures may help identify children who warrant closer assessment for concurrent encephalopathy and timely neurological evaluation.

  • Pediatric Leptomeningeal Glial Tumors: A Retrospective Case Series and Review of the Literature

    by SülEyman Şahin, Mehmet Alçi, BüşRa Kaygusuz Aydemir, Fatma Sargin, AbdülKerim Çokbiçer, Mustafa Gençeli, Halil Çelik, Özge Metin Akcan, Bekir Turgut, Ahmet Sami GüvEn

    Objective: Diffuse leptomeningeal glioneuronal tumor (DLGNT), including primary diffuse leptomeningeal oligodendroglial tumors (PDLOs) and leptomeningeal spread of high-grade gliomas, are rare pediatric neoplasms with diffuse leptomeningeal dissemination and limited parenchymal involvement. Their often nonspecific neurological symptoms frequently lead to misdiagnosis as infectious or inflammatory meningitis, complicating early identification. Methods: To investigate these diagnostic challenges, the authors retrospectively reviewed the records of 4 pediatric patients (2-13 years) diagnosed with leptomeningeal glial tumors over a 5-year period. Clinical features, neuroimaging, cerebrospinal fluid (CSF) findings, histopathology, treatment, and outcomes were analyzed. Results: All patients had subacute or chronic neurological symptoms, including gait ataxia (4/4), motor weakness (3/4), headache or vomiting (3/4), cognitive or behavioral decline (3/4), and seizures (2/4). Cerebrospinal fluid abnormalities contributed to diagnostic confusion but were not identical across all cases: pleocytosis was present in all patients, elevated protein was documented in those with available protein measurements, and reduced or relatively low glucose was observed only in some patients. Magnetic resonance imaging (MRI) demonstrated diffuse leptomeningeal involvement along the neuraxis in all patients, with cystic/nodular T2-hyperintense lesions and variable enhancement. Three patients were diagnosed within the DLGNT/PDLO spectrum and 1 with high-grade glioma with leptomeningeal dissemination. Hydrocephalus requiring ventriculoperitoneal shunting developed in 3/4 patients. All received chemotherapy; 1 required decompressive spinal surgery and craniospinal radiotherapy. At last follow-up, 3 patients were alive with neurological sequelae and 1 had died of progressive disease. Conclusion: These findings highlight that pediatric leptomeningeal glial tumors are diagnostically challenging and easily mistaken for chronic meningitis. Characteristic MRI findings, elevated CSF protein, and spinal dissemination are important clues.

  • Çocukluk Çağında Otizm Spektrum Bozukluğu: Epidemiyoloji

    by Fatma Sargın, Hurşit Ferahkaya, Ahmet Sami Güven

  • Open Access

    Çocukluk Çağında Otizm Spektrum Bozukluğu

    by Serkan Kırık, Fatma Sargın, Hurşit Ferahkaya, Ahmet Sami Güven, Mürşide Şahin, Esra Demirci, Elif Funda Şener, Ceyda Öney Yılmaz, Edibe Pembegül Yıldız, Emine Aylin Yılmaz, et al.

  • Assessment of the Impact of Social Anxiety on Primary Headache in Adolescents: A Case-Control Study

    by Fatma Sargin, Sadiye Sert, Büşra Kaygusuz Aydemir, Mehmet Alçi, Süleyman Şahin, Halil Çelik, Hüseyin Çaksen, Ahmet Sami Güven

  • Open Access

    Presymptomatic risdiplam treatment in an infant with homozygous SMN1 deletion and two SMN2 copies: age-appropriate motor development at 6 months

    by Süleyman Şahin, Mehmet Alçı, Büşra Kaygusuz Aydemir, Fatma Sargın, Halil Çelik

    Background: Spinal muscular atrophy (SMA) is a progressive neuromuscular disorder caused by biallelic SMN1 deletion or mutation, leading to degeneration of anterior horn motor neurons. Newborn screening enables presymptomatic diagnosis, and timely initiation of disease-modifying therapy is associated with improved outcomes. Risdiplam is an oral SMN2 pre‑mRNA splicing modifier approved for SMA across a broad age range. Case: A male infant with a positive newborn screening result was referred at 10 days of age. Confirmatory testing demonstrated a homozygous SMN1 exon 7 deletion with two copies of SMN2. Neurological examination revealed generalized areflexia with otherwise normal spontaneous antigravity movements. Due to administrative issues, risdiplam was initiated at 1 month of age. Before treatment initiation, the CHOP-INTEND score was 28/64. At 6 months of age, repeat assessment showed an increase to 41/64; both evaluations were performed by the same experienced physiotherapist. At 6 months, gross motor development was age-appropriate; deep tendon reflexes remained absent, and no bulbar or respiratory involvement was observed. Conclusion: This case supports that early presymptomatic risdiplam initiation may be associated with near‑typical early motor development in infants with two SMN2 copies, although residual signs such as areflexia can persist. Efforts should focus on minimizing delays, with the goal of initiating therapy as early as possible after birth (ideally within the first two weeks).

  • Open Access

    Evaluating the readability, understandability, quality, and popularity of online materials about epilepsy in children

    by Fatma Sargin, Mehmet Alçı, Büşra Kaygusuz Aydemir, Süleyman Şahin, Hüseyin Çaksen, Ahmet Sami Güven

    Childhood epilepsy is one of the most common neurological disorders worldwide, significantly affecting cognitive, emotional, and social development. As car

  • Open Access

    Evaluation of the Readability and Quality of Online Turkish Materials in the Field of Pediatric Neurology

    by Fatma Sargın, Mehmet Alçı, Büşra Kaygusuz Aydemir, Süleyman Şahin, Hüseyin Çaksen, Ahmet Sami Güven

    Objective: Accessible, high-quality online health information is essential for patient under standing, particularly in specialized fields such as pediatric neurology. However, little is known about the readability and quality of Turkish-language online resources in this area. To evaluate the readability and quality of Turkish online educational materials on pediatric neurology using validated readability formulas and standardized quality assessment criteria. Materials and Methods: An Internet-based Patient Educational Material search was con ducted using Google with the terms “çocuk nöroloji” /''child neurology'' and “pediatrik nöroloji”/''pediatric neurology''. After applying exclusion criteria, 69 websites were included. These websites were categorized into 2 groups: Group 1 (academic and hospital websites) and Group 2 (physician and general health information websites). Readability was assessed using the Ateşman and Bezirci-Yılmaz formulas, while website quality was evaluated using the Journal of the American Medical Association (JAMA) benchmark criteria. Results: The median Ateşman Readability Score was 36.63, and the Bezirci-Yılmaz score was 7.04, indicating difficult readability. Only 13.04% of websites met ≥3 JAMA criteria and were classified as high quality. Group 2 (physician and general health information websites) had significantly higher quality scores than Group 1 (academic and hospital websites) (P < .001). No significant differences were found between groups in terms of readability. Conclusion: Most Turkish-language pediatric neurology websites are difficult to read and of low quality. Quality was higher in non-academic sources, although readability remained inadequate across all sources. These findings underscore the need for developing readable and high-quality online educational materials in pediatric neurology to enhance public under standing and informed health decisions.


  • Hematological Parameters and Systemic Inflammatory Markers in Children with Viral Acute Lower Respiratory Tract Infections

    by Sadiye Sert, Fatma Sargın, Şerife Karaçal Say, Berna Erayman, Ebru Buldu

    Objective Viral acute lower respiratory tract infections (ALRTIs) are a leading cause of morbidity and mortality in children, particularly those under 5 years. Accurate diagnosis and timely management are crucial to improve outcomes. This study aimed to address the lack of comparative analysis between hematological and systemic inflammatory markers concerning established disease severity scores in children with viral ALRTIs. We sought to evaluate the correlations between these markers and severity scores to identify which parameters provide the most reliable predictive value for assessing the severity of ALRTI diagnoses in this population. Methods This retrospective cross-sectional study included 191 children hospitalized with viral ALRTIs. Hematological parameters and systemic inflammatory markers were analyzed. The pediatric respiratory severity score (PRESS) was used to assess disease severity. Results Significant differences in some hematological parameters and systemic inflammatory markers across severity groups were observed. Significant correlations were found between PRESS and various hematological parameters, including white blood cell count, lymphocyte count, monocyte count, platelet count, red cell distribution width, plateletocrit, and lymphocyte-to-C-reactive protein ratio. Multivariate analysis identified PRESS, hemoglobin level, and mean platelet volume-to-lymphocyte ratio as independent predictors of pediatric intensive care unit (PICU) admission. Receiver operating characteristic analysis revealed that platelet count had the highest area under the curve for predicting PICU admission. Conclusion We found that values of hematological parameters and systemic inflammatory markers together with clinical severity scores can be used to assess the severity of ALRTIs in children. The identified cutoff values for these markers can aid in predicting PICU admission risk.